A multitude of reports indicate varying degrees of investor sentiment for **Abbott Laboratories (ABT)**. Several advisory and asset management firms including RFG Advisory LLC, Cullen Investment Group LTD, and Fisher Management LLC have increased or initiated their holdings in Abbott Laboratories, suggesting **trust and growth potential**. Despite this, Los Angeles Capital Management LLC, NBC Securities, and Trust Co. undertook share sell-offs. A series of investment groups and financial advisories watched Abbott's move, considering stock trends, earnings calls, and investment attractiveness. Abbott's Q1 2024 earnings outperformed estimates, providing a **positive outlook**. However, due to Q2 guidance disappointing compared to earnings beat, the stock recently underperformed among competitors. Continuous focus remains on the company's financial performance and prospective development of its stock, which some see as a possible 'multi-bagger'. Despite a volatile environment, some investors retain their positions, while others see potential in Abbott as a **dividend growth stock**. Institutional shareholders hold the majority (77%) of the company. The examination of insider trading suggests some hesitance among executives. However, Abbott stocks have been given technical rating upgrades.
Abbott Laboratories ABT News Analytics from Wed, 18 Oct 2023 07:00:00 GMT to Sun, 23 Jun 2024 17:28:02 GMT -
Rating 0
- Innovation 5
- Information 7
- Rumor -3
